STOCK TITAN

MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

MIMEDX Group (Nasdaq: MDXG) has announced its upcoming fourth quarter and full year 2024 financial results release, scheduled for after market close on Wednesday, February 26, 2025. The company's senior management team will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results.

Investors can access the conference call through a webcast or by phone, with separate dial-in numbers provided for U.S. (877-407-6184) and international investors (201-389-0877). A replay of the webcast will be available on the MIMEDX website for approximately 30 days following the event.

MIMEDX Group (Nasdaq: MDXG) ha annunciato il rilascio dei risultati finanziari del quarto trimestre e dell'intero anno 2024, previsto dopo la chiusura del mercato il mercoledì 26 febbraio 2025. Il team di gestione senior dell'azienda ospiterà un webcast e una conferenza telefonica alle 16:30 ora orientale per discutere i risultati.

Gli investitori possono accedere alla conferenza telefonica tramite un webcast o per telefono, con numeri di accesso distinti per gli investitori statunitensi (877-407-6184) e internazionali (201-389-0877). Una registrazione del webcast sarà disponibile sul sito web di MIMEDX per circa 30 giorni dopo l'evento.

MIMEDX Group (Nasdaq: MDXG) ha anunciado la próxima publicación de sus resultados financieros del cuarto trimestre y del año completo 2024, programada para después del cierre del mercado el miércoles 26 de febrero de 2025. El equipo de alta dirección de la compañía llevará a cabo un webcast y una llamada de conferencia a las 4:30 p.m. hora del Este para discutir los resultados.

Los inversores pueden acceder a la llamada de conferencia a través de un webcast o por teléfono, con números de acceso separados para inversores de EE.UU. (877-407-6184) e inversores internacionales (201-389-0877). Una grabación del webcast estará disponible en el sitio web de MIMEDX durante aproximadamente 30 días después del evento.

MIMEDX Group (Nasdaq: MDXG)는 2024년 4분기 및 연간 재무 결과 발표가 2025년 2월 26일 수요일 시장 마감 후 예정되어 있음을 발표했습니다. 회사의 고위 경영진은 결과를 논의하기 위해 동부 표준시 기준 오후 4:30에 웹캐스트 및 컨퍼런스 콜을 개최합니다.

투자자는 웹캐스트 또는 전화를 통해 컨퍼런스 콜에 접속할 수 있으며, 미국 투자자(877-407-6184)와 해외 투자자를 위한 별도의 다이얼 인 번호가 제공됩니다 (201-389-0877). 웹캐스트의 재생 녹화는 이벤트 이후 약 30일 동안 MIMEDX 웹사이트에서 제공됩니다.

MIMEDX Group (Nasdaq: MDXG) a annoncé la prochaine publication de ses résultats financiers pour le quatrième trimestre et l'ensemble de l'année 2024, prévue après la fermeture du marché le mercredi 26 février 2025. L'équipe de direction senior de l'entreprise animera un webcast et une conférence téléphonique à 16h30, heure de l'Est, pour discuter des résultats.

Les investisseurs peuvent accéder à la conférence téléphonique via un webcast ou par téléphone, avec des numéros d'appel distincts fournis pour les investisseurs américains (877-407-6184) et internationaux (201-389-0877). Un enregistrement du webcast sera disponible sur le site Web de MIMEDX pendant environ 30 jours après l'événement.

MIMEDX Group (Nasdaq: MDXG) hat die bevorstehende Veröffentlichung der Finanz Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 bekannt gegeben, die nach Marktschluss am Mittwoch, den 26. Februar 2025 stattfinden wird. Das Führungsteam des Unternehmens wird um 16:30 Uhr Eastern Time ein Webcast und eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.

Investoren können über einen Webcast oder per Telefon auf die Telefonkonferenz zugreifen, wobei separate Einwahlnummern für US-Investoren (877-407-6184) und internationale Investoren (201-389-0877) bereitgestellt werden. Eine Aufzeichnung des Webcasts wird etwa 30 Tage nach der Veranstaltung auf der MIMEDX-Website zur Verfügung stehen.

Positive
  • None.
Negative
  • None.

MARIETTA, Ga., Feb. 05, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2024 after the market close on Wednesday, February 26, 2025. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13751444

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com


FAQ

When will MIMEDX (MDXG) release Q4 and full year 2024 earnings?

MIMEDX will release its Q4 and full year 2024 earnings after market close on Wednesday, February 26, 2025.

What time is MIMEDX's (MDXG) Q4 2024 earnings call?

MIMEDX's Q4 2024 earnings call is scheduled for 4:30 p.m. Eastern Time on February 26, 2025.

How can investors access MIMEDX's (MDXG) Q4 2024 earnings call?

Investors can access the call via webcast or by phone: U.S. investors can dial 877-407-6184, and international investors can dial 201-389-0877, using Conference ID 13751444.

How long will MIMEDX's (MDXG) Q4 2024 earnings call replay be available?

A replay of the webcast will be available for approximately 30 days on MIMEDX's website at www.mimedx.com following the event.

Mimedx Group Inc

NASDAQ:MDXG

MDXG Rankings

MDXG Latest News

MDXG Stock Data

1.15B
143.00M
2.54%
67.63%
3.04%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
MARIETTA